MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.
MENARINI AND ART: TRADITION AND INNOVATION
Art monographs, specialist magazines dedicated to the great masters and more.
Today, with ‘Pills of Art’, Menarini enters the city’s museums to reveal some of the curious facts on the works of the most well-known Renaissance painters. An initiative which confirms the company’s affiliation with art, a close connection which has led them to publish, each year and for more than six decades, an art monograph dedicated to the great masters of artistic beauty: a tradition which dates back to 1956 and which has continue and evolved over time, right up to today. In this section, through a series of short videos, we shall take a trip through the history of our art publications, sharing anecdotes on some of the most famous works which have been, or shall become, the topic of volumes to come. Our exceptional guide on this ‘adventure’ will be the Director of the Uffizi Galleries, Eike Schmidt.
Madonna of the Caves by Mantegna
Andrea Mantegna realizes this small but important painting in Rome. The title comes from the quarries reproduced behind the Madonna and child, where stonecutters are working slabs and columns. Let us look at the glance of the Virgin and the child, sad because they are aware of the future sacrifice of Jesus. Look with us at this marvelous work. Mantegna about 1488 - 1490.
"Concession granted by Italian Ministry for Cultural Heritage and Activities. Reproduction or duplication of any content and by whatever means is prohibited".
All video of pills of art are also available in
Subscribe to the newsletter
Subscribe to the newsletter to be updated on Menarini news.
Media Contact
To access the service it is necessary to declare to have read the privacy information.